 |
Your Future in Pharmacy: Attend an Ownership Workshop
You need the right tools to run a stronger business and be a better owner to survive and thrive in today's highly competitive health care marketplace. This proven program is ideal both for those thinking about buying their first pharmacy or opening another. Register now for a 2012 Pharmacy Ownership Workshop, sponsored by McKesson and in part by Pharmacists Mutual. Find out what it takes to own and operate a successful pharmacy. The first workshop is scheduled for Feb. 24-26 in Dallas. Seating is limited to ensure a high degree of personalized learning and interaction. Click here to register. |
 |
Drugs and Treatment
Antidepressant Use Linked to Increased Pulmonary Hypertension Risk in Infants
New York Times (01/13/12) Dell'Antonia, KJ
A study published in the British Medical Journal provides stronger evidence that taking some antidepressants during pregnancy doubles the risk of a baby developing pulmonary hypertension. The research, based on read more...
Return to Headlines
CDC: Prescription painkiller Overdoses Constitute ‘U.S. Epidemic’
Washington Post (01/13/12) Huget, Jennifer LaRue
An article in a recent CDC bulletin highlights the extent to which people in this country abuse — and overdose on — prescription drugs. According to the report, unintentional drug overdose death rates have risen read more...
Return to Headlines
FDA Issues Warning About Lymphoma Drug Brentuximab
Medscape (01/13/12) Mulcahy, Nick
The FDA has issued a warning to healthcare professionals about the lymphoma drug brentuximab (Adcetris, Seattle Genetics). Two new cases of progressive multifocal leukoencephalopathy (PML), which is a rare but read more...
Return to Headlines
Lundbeck Launches Bipolar Drug Sycrest in the UK
InPharm (01/17/12) Adams, Ben
Lundbeck has launched its antipsychotic drug Sycrest in the U.K. to treat acute attacks of bipolar I disorder. Sycrest (asenapine) is now available as a sublingual (quick release) treatment for patients in read more...
Return to Headlines
Nearly 300 Drugs for Children Under Development in USA
thepharmaletter.com (01/15/2012)
U.S. biopharmaceutical companies are researching 282 medicines to help meet the unique health care needs of children and adolescents, according to a new report released by the Pharmaceutical Research and read more...
Return to Headlines
New Data on Rasilez in Combination With Certain BP Drugs
thepharmaletter.com (01/15/2012)
Researchers at St Michael's Hospital in Toronto, Canada, have published a study showing the risk of using drug major Novartis’prescription drug Rasilez (aliskiren), a renin inhibitor licensed for the treatment of read more...
Return to Headlines
|
|
|
Industry News
Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis
Genentech Press Release (01/13/12)
Genentech has announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company's investigational drug delivery device, designed to read more...
Return to Headlines
Novartis Joins Pfizer, Merck, AstraZeneca In Layoffs
Investor's Business Daily (01/13/12) Rich, Gillian
Novartis has announced that it will lay off 1,960 workers in the United States and shut three of its subsidiaries, continuing a cost-cutting trend in the pharmaceutical industry. In 2010 Pfizer started implementing read more...
Return to Headlines
Novo Nordisk Partners with Paula Deen and Sons, Bobby and Jamie Deen, on National Diabetes Initiative
Novo Nordisk Press Release (01/17/12)
Novo Nordisk is teaming up with American cooking stars Paula Deen and her sons, Bobby and Jamie Deen, to launch Diabetes in a New Light, a national initiative to help adults find simple ways to read more...
Return to Headlines
|
|
|
Healthcare Legislation & Regulation and Medicaid/Medicare
FDA Unveils User Fee Program for Generic Drugs
Associated Press (01/13/12)
The FDA would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with industry released by the read more...
Return to Headlines
New State Program Will Help Track Prescription Drug Abuse
NorthJersey.com (01/14/12) Lipman, Harvy
New Jersey has launched a database monitoring use of dangerous drugs with the intent of helping doctors spot abusers more quickly and authorities stop drug dealers. The database has been collecting information since read more...
Return to Headlines
Thousands Mine Rx Database
Tampa Tribune (01/16/12) Reyes, Ray
Some 5,787 medical professionals have registered to use the Electronic Florida Online Reporting of Controlled Substances Evaluation, or E-FORCSE, database. Within two months of the launch, those health professionals checked read more...
Return to Headlines
U.S. to Force Drug Firms to Report Money Paid to Doctors
New York Times (01/16/12) Pear, Robert
The federal government is poised to require drug companies to disclose the payments they make to doctors for research, consulting, speaking, travel and entertainment. Under the new standards, if a company has read more...
Return to Headlines
|
Abstract News © Copyright 2012 INFORMATION, INC.
 |
|
|
FEATURED SPONSOR:
|
|
